None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The subjects of this study were patients who were diagnosed with colorectal cancer and hospitalized for minimally invasive (laparoscopic or robotic) colectomy at Seoul National University Hospital. The control group consisted of patients who received the standard ERAS program from November 1, 2024, to June 30, 2025, while the experimental group consisted of patients who received the advanced practice nurse-led ERAS program from August 1, 2025, to October 31, 2025. The experimental group was prospectively recruited from adult patients aged 19 years and older, who were diagnosed with colorectal cancer and underwent minimally invasive colectomy at Seoul National University Hospital's Department of Colorectal Surgery. These patients voluntarily consented to participate in the ERAS program and the study. The control group was retrospectively selected from patients who received the same diagnosis and surgery between November 2024 and June 2025, prior to the implementation of the advanced practice nurse-led intervention in this study, and were randomly selected from the electronic medical records, with recovery progress and key clinical data available for review.
Exclusion criteria
Exclusion criteria: In the experimental group, patients who were unable to communicate or could not complete the informed consent process were excluded, while in the control group, patients were excluded if key clinical data related to recovery progress during the hospitalization period were missing or incomplete in the electronic medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to First Flatus | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life (EQ-5D-5L);Early Ambulation;Step Count | — |
Countries
Korea, Republic of
Contacts
Seoul National University Hospital